Nuwellis, Inc. (NUWE) |
|
8.55 0.1 (1.18%)
|
02-02 16:00 |
|
Open: |
8.25 |
Pre. Close: |
8.45 |
|
High:
|
9.11 |
Low:
|
8.25 |
|
Volume:
|
199,817 |
Market Cap:
|
5(M) |
|
|
|
Technical analysis |
as of: 2023-02-02 4:14:17 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 14.47 One year: 19.03 |
| Support: |
Support1: 6.07 Support2: 5.05 |
| Resistance: |
Resistance1: 12.39 Resistance2: 16.29 |
| Pivot: |
7.87  |
| Moving Average: |
MA(5): 8.21 MA(20): 7.94 
MA(100): 24.37 MA(250): 55.68 |
| MACD: |
MACD(12,26): -0.7 Signal(9): -1 |
| Stochastic oscillator: |
%K(14,3): 48.3 %D(3): 41.5 |
| RSI: |
RSI(14): 47.7 |
| 52-week: |
High: 185 Low: 0.48 |
| Average Vol(K): |
3-Month: 459 (K) 10-Days: 574 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NUWE ] has closed below upper band by 15.5%. Bollinger Bands are 91.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 66 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.75 - 9.81 |
9.81 - 9.86 |
|
Low:
|
8.19 - 8.24 |
8.24 - 8.29 |
|
Close:
|
8.37 - 8.46 |
8.46 - 8.54 |
|
Company Description |
|
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. |
Headline News |
Wed, 01 Feb 2023
The City announces Cape Town's calendar of events for 2023 - CapeTown ETC
Thu, 19 Jan 2023
Premarket Mover: Nuwellis Inc (NUWE) Up 1.63% - InvestorsObserver
Tue, 10 Jan 2023
Should You Buy Nuwellis Inc (NUWE) Stock Tuesday Morning? - InvestorsObserver
Tue, 10 Jan 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Tue, 10 Jan 2023
Pre-market Movers: SHC, OSH, FRO, NUWE, LCFY… - RTTNews
Thu, 05 Jan 2023
Healthcare Stocks Making Moves Thursday: BLPH, ABVC, NVCR, VYNT, NUWE, GERN, OPGN, TCBP - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
11 (M) |
| Shares Float |
10 (M) |
|
% Held by Insiders
|
10.2 (%) |
|
% Held by Institutions
|
3.4 (%) |
|
Shares Short
|
773 (K) |
|
Shares Short P.Month
|
70 (K) |
Stock Financials |
|
EPS
|
-3.75 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.84 |
|
Profit Margin (%)
|
-240.9 |
|
Operating Margin (%)
|
-239.7 |
|
Return on Assets (ttm)
|
-44.3 |
|
Return on Equity (ttm)
|
-84.3 |
|
Qtrly Rev. Growth
|
-11.9 |
|
Gross Profit (p.s.)
|
0.42 |
|
Sales Per Share
|
0.72 |
|
EBITDA (p.s.)
|
-1.7 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-17 (M) |
|
Levered Free Cash Flow
|
-11 (M) |
Stock Valuations |
|
PE Ratio
|
-2.28 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
3 |
|
Price to Sales
|
11.81 |
|
Price to Cash Flow
|
-5.17 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-10-18 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
